BiogenIdec

3 Bio Companies Facing The Patent Cliff

3 Bio Companies Facing The Patent Cliff

Seeking Alpha

7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013

7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013

Seeking Alpha

Biogen's New Hemophilia Drug Could Replace Pfizer's Old One

Biogen's New Hemophilia Drug Could Replace Pfizer's Old One

Forbes

Battle Lines Drawn in the MS Market

Battle Lines Drawn in the MS Market

Motley Fool

Multiple sclerosis drugs seen gaining traction

Multiple sclerosis drugs seen gaining traction

Marketwatch

Is Biogen Too Good To Be True?

Is Biogen Too Good To Be True?

Seeking Alpha

Biogen, Shire, Novo top pharma ranking of shareholder value

Biogen, Shire, Novo top pharma ranking of shareholder value

Fierce Pharma

Rituxan And Its Biosimilar Competitors

Rituxan And Its Biosimilar Competitors

Seeking Alpha

Biogen Second-Quarter Profit Rises As Avonex Sales Increase

Biogen Second-Quarter Profit Rises As Avonex Sales Increase

Bloomberg

Earnings Preview: Biogen

Earnings Preview: Biogen

Yahoo/Zacks